Nam Vinh Nguyen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Machine Learning

Health Insurance

Clinical Practice

Top Venues

Open forum infectious diseases

JAC-antimicrobial resistance

Oxford University Clinical Research Unit

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oxford University Clinical Research Unit Feb 01 2019

Vietnam

PhD student :: Hanoi Unit

Hanoi University of Pharmacy Aug 01 2010

Vietnam

Researcher :: Department of Pharmaceutical Management and Economics

Publications

Nam Vinh Nguyen, Nga Thi Thuy Do, Huong Thi Lan Vu, Phuong Bich Bui, Thai Quang Pham, Vinh Thanh Khuong, Anh Tuan Lai, H Rogier van Doorn, Sonia O Lewycka
Understanding Acceptability and Willingness-to-pay for a C-reactive Protein Point-of-care Testing Service to Improve Antibiotic Dispensing for Respiratory Infections in Vietnamese Pharmacies: A Mixed-methods Study. Open forum infectious diseases 11 (8) (2024)
Nam Vinh Nguyen, Nga Thi Thuy Do, Huong Thi Lan Vu, Phuong Bich Bui, Thai Quang Pham, Vinh Thanh Khuong, Anh Tuan Lai, H Rogier van Doorn, Sonia O Lewycka
Understanding Acceptability and Willingness-to-pay for a C-reactive Protein Point-of-care Testing Service to Improve Antibiotic Dispensing for Respiratory Infections in Vietnamese Pharmacies: A Mixed-methods Study. Open forum infectious diseases 11 (8) (2024)
Quang Ngo Nguyen, Nam Vinh Nguyen, Dung Thi Phuong Nguyen, Celine Vidaillac, Phuong Thi Minh Trinh, H Rogier van Doorn, Guy E Thwaites, Evelyne Kestelyn, Ha Thi Nhi Vo
Development of a Good Clinical Practice inspection checklist to assess clinical trial sites in Vietnam. BMJ open 11 (7) (2021)
Nam Vinh Nguyen, Nga Thi Thuy Do, Chuc Thi Kim Nguyen, Toan Khanh Tran, Phuc Dang Ho, Hanh Hong Nguyen, Thi Lan Huong Vu, Heiman F L Wertheim, Hindrik Rogier van Doorn, Sonia Lewycka
Community-level consumption of antibiotics according to the AWaRe (Access, Watch, Reserve) classification in rural Vietnam. JAC-antimicrobial resistance 2 (3) (2020)